• 日本内科学会（認定医・総合内科専門医）
• 日本呼吸器学会（呼吸器専門医・指導医）
• 日本感染症学会（感染症専門医・指導医）
• 日本結核・非結核性抗酸菌症学会（専門医・指導医）

1）Mycoplasma pneumoniae Pneumonia: Differential Diagnosis by Computerized Tomography.  Nei T, Yamano Y, Sakai F, Kudoh S. Intern Med. 2007; 46(14): 1083-7. 2007

2）A case of bucillamine-induced interstitial pneumonia with positive lymphocyte stimulation test for bucillamine using bronchoalveolar lavage lymphocytes.  Saito Y, Nei T, Abe S, Usuki J, Azuma A, Nakayama T, Fukuda Y, Kudoh S.  Intern Med. 46(20): 1739-43, 2007.

3）Microbial substitution of Mycobacterium avium-intracellulare to Mycobacterium abscessus during clinical course. Nei T , Saitoh T, Morimoto K, Watanabe K, Hayashihara K, Azuma A, Kudoh S. J Infect Chemother. 2007 (5):343-5. 2007.

4）Preventive Effect of Sulfamethoxasole-trimethoprim on Pneumocystis jiroveci Pneumonia in Patients with Interstitial Pneumonia. Enomoto T, Azuma A, Matsumoto A, Nei T, Fujita K, Hattori K, Saito Y, Abe S, Usuki J, Kudoh S., Intern. Med. 47(1): 15-20, 2008.

5）Transbronchial biopsy is clinically useful in classifying patients with interstitial pneumonia associated with polymyositis and dermatomyositis.  Mochimaru H, Kawamoto M, Enomoto T, Saitoh Y, Abe S, Nei T, Fukuda Y, Kudoh S. Respirology. 2008;13(6):863-70.

6）A cell-free assay to estimate the neutralizing capacity of granulocyte-macrophage colony-stimulating factor autoantibodies. Urano S, Kaneko C, Nei T, Motoi N, Tazawa R, Watanabe M, Tomita M, Adachi T, Kanazawa H, Nakata K. J Immunol Methods. 2010;360(1-2):141-8.

7）Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2R  Tanaka T, Motoi M, Tsuchihashi Y, Tazawa R, Kaneko C, Nei T, Yamamoto T, Hayashi T, Tagawa T, Nagayasu T, Kuribayashi F, Ariyoshi K, Nakata K, Morimoto K, J Med Genet. 2011;48(3):205-9.

8）A cell free assay system estimating the neutralizing capacity of GM-CSF antibody using recombinant soluble GM-CSF receptor. Urano S, Tazawa R, Nei T, Motoi N, Watanabe M, Igarashi T, Tomita M, Nakata K. J Vis Exp. 2011 27;(52). pii: 2742.

9）Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis. Ohashi K, Sato A, Takada T, Arai T, Nei T, Kasahara Y, Motoi N, Hojo M, Urano S, Ishii H, Yokoba M, Eda R, Nakayama H, Nasuhara Y, Tsuchihashi Y, Kaneko C, Kanazawa H, Ebina M, Yamaguchi E, Kirchner J, Inoue Y, Nakata K, Tazawa R. Respir Med. 2012;106(2):284-93.

10）A case of streptococcal toxic shock syndrome due to Group G streptococci identified as Streptococcus dysgalactiae subsp. equisimilis. Nei T, Akutsu K, Shima A, Tsuboi I, Suzuki H, Yamamoto T, Tanaka K, Shinoyama A, Kojima Y, Washio Y, Okawa S, Sonobe K, Norose Y, Saito R.J Infect Chemother. 2012;18(6):919-24.

11）IgM-type GM-CSF autoantibody is etiologically a bystander but associated with IgG-type autoantibody production in autoimmune pulmonary alveolar proteinosis. Nei T, Urano S, Motoi N, Takizawa J, Kaneko C, Kanazawa H, Tazawa R, Nakagaki K, Akagawa KS, Akasaka K, Ichiwata T, Azuma A, Nakata K. Am J Physiol Lung Cell Mol Physiol. 2012;302(9):L959-64.

12）First report of infectious pericarditis due to Bordetella holmesii in an adult patient with malignant lymphoma. Nei T, Hyodo H, Sonobe K, Dan K, Saito R. J Clin Microbiol. 2012;50(5):1815-7.

13）Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis. Ohashi K, Sato A, Takada T, Arai T, Kasahara Y, Hojo M, Nei T, Nakayama H, Motoi N, Urano S, Eda R, Yokoba M, Tsuchihashi Y, Nasuhara Y, Ishii H, Ebina M, Yamaguchi E, Inoue Y, Nakata K, Tazawa R. Eur Respir J. 2012;39(3):777-80.

14）Giant left atrium due to mitral stenosis with massive atelectasis: a successful case with perioperative approach. Tanita A, Hosokawa Y, Tomiyama T, Kato M, Matsuda J, Sawai K, Arita Y, Aokage T, Suzuki H, Murata H, Miyachi H, Shibui T, Nei T, Akutsu K, Yamamoto T, Takeda S, Nitta T, Tanaka K, Mizuno K, Tanaka K. Int J Cardiol. 2013;163(2):e23-5.

15）A non-HIV case with disseminated Mycobacterium kansasii disease associated with strong neutralizing autoantibody to interferon-γ. Nei T, Okabe M, Mikami I, Koizumi Y, Mase H, Matsuda K, Yamamoto T, Takeda S, Tanaka K, Dan K. Respir Med Case Rep. 2012;8:10-3.

16）Descending necrotizing mediastinitis associated with Lactobacillus plantarum. Nei T, Inai S, Mikami I, Sato A, Okamoto J, Yokoshima K, Nakamizo M, Haraguchi S, Sonobe K, Saito R. BMC Infect Dis. 2013;13:398.

17）Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy. Tazawa R, Inoue Y, Arai T, Takada T, Kasahara Y, Hojo M, Ohkouchi S, Tsuchihashi Y, Yokoba M, Eda R, Nakayama H, Ishii H, Nei T, Morimoto K, Nasuhara Y, Ebina M, Akira M, Ichiwata T, Tatsumi K, Yamaguchi E, Nakata K. Chest. 2014;145(4):729-37.

18）Light chain (κ/λ) ratio of GM-CSF autoantibodies is associated with disease severity in autoimmune pulmonary alveolar proteinosis. Nei T, Urano S, Itoh Y, Kitamura N, Hashimoto A, Tanaka T, Motoi N, Kaneko C, Tazawa R, Nakagaki K, Arai T, Inoue Y, Nakata K. Clin Immunol. 2013;149(3):357-64.

19）Miliary tuberculosis with indeterminate interferon gamma release assay results. Nei T, Fujisawa Y, Izumi Y, Tetsuka A, Arita Y, Murata H, Sawai K, Kitamura M, Miyachi H,Hosokawa Y, Akutsu K, Yamamoto T, Tanaka K, Shinoyama A. Intern Med. 2013;52(22):2583-5. 

20）Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis. Inomata M, Kamio K, Azuma A, Matsuda K, Kokuho N, Miura Y, Hayashi H, Nei T, Fujita K, Saito Y, Gemma A. Respir Res. 2014 Feb 8;15:16.

21）Clinical experience with pirfenidone in five patients with scleroderma-related interstitial lung disease. Miura Y, Saito T, Fujita K, Tanaka T, Tsunoda Y, Azuma A, Nei T, Yatagai Y, Rin S, Sekine A, Hayashihara K. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(3):235-8.

22）Pulmonary Nocardiosis due to Nocardia asiatica in an Immunocompetent Host. Okawa S, Sonobe K, Nakamura Y, Nei T, Kamio K, Gemma A. J Nippon Med Sch. 2015;82(3):159-62.

23）Two cases with bacteremia suspected to be due to relatively rare Pseudomonas (Flavimonas) oryzihabitans. Nei T, Sonobe K, Onodera A, Itabashi T, Yamaguchi H, Maeda M, Saito R. J Infect Chemother. 2015;21(10):751-5.

24）Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study. Akasaka K, Tanaka T, Kitamura N, Ohkouchi S, Tazawa R, Takada T, Ichiwata T, Yamaguchi E, Hirose M, Arai T, Nakano K, Nei T, Ishii H, Handa T, Inoue Y, Nakata K. BMC Pulm Med. 2015;15:88.

25）Streptobacillus moniliformis bacteremia in a rheumatoid arthritis patient without a rat bite: a case report. Nei T, Sato A, Sonobe K, Miura Y, Takahashi K, Saito R. BMC Res Notes. 2015;8(1):694.

26）An Outbreak of Food-Borne Typhoid Fever Due to Salmonella enterica Serotype Typhi in Japan Reported for the First Time in 16 Years. Kobayashi T, Kutsuna S, Hayakawa K, Kato Y, Ohmagari N, Uryu H, Yamada R, Kashiwa N, Nei T, Ehara A, Takei R, Mori N, Yamada Y, Hayasaka T, Kagawa N, Sugawara M, Suzaki A, Takahashi Y, Nishiyama H, Morita M, Izumiya H, Ohnishi M. Am J Trop Med Hyg. 2015 Nov 30. pii: 15-0484.

27）Acute Lung Injury Accompanying Alveolar Hemorrhage Associated with Flu Vaccination in the Elderly. Satoh E, Nei T, Kuzu S, Chubachi K, Nojima D, Taniuchi N, Yamano Y, Gemma A. Intern Med. 2015;54(24):3193-6.

28）A Semiquantitative Computed Tomographic Grading System for Evaluating Therapeutic Response in Pulmonary Alveolar Proteinosis. Tokura S, Akira M, Okuma T, Tazawa R, Arai T, Sugimoto C, Matsumuro A, Hirose M, Takada T, Nakata K, Ishii H, Kasahara Y, Hojo M, Ohkouchi S, Tsuchihashi Y, Yokoba M, Eda R, Nakayama H, Nei T, Morimoto K, Nasuhara Y, Ebina M, Ichiwata T, Tatsumi K, Yamaguchi E, Inoue Y. Ann Am Thorac Soc. 2017 Sep;14(9):1403-1411.

29）Risk factors of catheter-related bloodstream infection caused by Bacillus cereus: Case-control study in 8 teaching hospitals in Japan. Kutsuna S, Hayakawa K, Kita K, Katanami Y, Imakita N, Kasahara K, Seto M, Akazawa K, Shimizu M, Kano T, Nei T, Hayashi T, Mori N, Yabuki T, Ohmagari N. Am J Infect Control. 2017 Nov 1;45(11):1281-1283.

30）Neck abscess due to Salmonella Choleraesuis: case study and literature review. Sugimoto R, Suzuki H, Nei T, Tashiro A, Washio Y, Sonobe K, Nakamura Y, Wakayama N, Inai S, Izumiya H. JMM Case Rep. 2017 Sep 1;4(8):e005109.

31）Reduced incidence of lung cancer in patients with idiopathic pulmonary fibrosis treated with pirfenidone. Miura Y, Saito T, Tanaka T, Takoi H, Yatagai Y, Inomata M, Nei T, Saito Y, Gemma A, Azuma A. Respir Investig. 2018 Jan;56(1):72-79.

32）Kodamaea ohmeri fungemia in severe burn: Case study and literature review. Tashiro A, Nei T, Sugimoto R, Watanabe A, Hagiwara J, Takiguchi T, Yokota H, Kamei K. Med Mycol Case Rep. 2018 Jul 20;22:21-23.

33）Memory B cell pool of autoimmune pulmonary alveolar proteinosis patients contains higher frequency of GM-CSF autoreactive B cells than healthy subjects. Nei T, Urano S, Motoi N, Hashimoto A, Kitamura N, Tanaka T, Nakagaki K, Takizawa J, Kaneko C, Tazawa R, Nakata K. Immunol Lett. 2019 Aug;212:22-29.

34) Acute kidney injury in non-intensive care unit and intensive care unit patients treated with vancomycin and piperacillin-tazobactam. Inage S, Nakamura S, Isoe Y, Okamoto S, Uetake S, Murakami M, Yamaguchi A, Morishima M, Nei T, Ise Y, Katayama S. J Nippon Med Sch. 2019 Oct 15. doi: 10.1272/jnms.JNMS.2020_87-203. [Epub ahead of print]

35）Infective endocarditis caused by Cardiobacterium valvarum. Yohei Washio, Shun-ichiro Sakamoto, Ryoichi Saito, Takahito Nei, Masayo Morishima, Akihiro Shinoyama, Ayaka Tashiro, Ryoji Sugimoto. Access Microbiology 2019;1 DOI 10.1099/acmi.0.000040

36）Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae. Hayakawa K, Nakano R, Hase R, Shimatani M, Kato H, Hasumi J, Doi A, Sekiya N, Nei T, Okinaka K, Kasahara K, Kurai H, Nagashima M, Miyoshi-Akiyama T, Kakuta R, Yano H, Ohmagari N. J Antimicrob Chemother. 2020 Mar 1;75(3):697-708.

37）Fatal fulminant Clostridioides difficile colitis caused by Helicobacter pylori eradication therapy; a case report. Nei T, Hagiwara J, Takiguchi T, Yokobori S, Shiei K, Yokota H, Senoh M, Kato H. J Infect Chemother. 2020 Mar;26(3):305-308.

【原著･和文】

1）気管支拡張で発見され原発性免疫不全症候群が疑われた一卵性双生児の姉妹例：榎本達治（東京都立広尾病院 呼吸器科）, 吾妻安良太, 三浦由記子, 高久多希朗, 松本亜紀, 根井貴仁, 阿部信二, 臼杵二郎, 工藤翔二：Therapeutic Research（0289-8020）25巻7号 Page1505-1508（2004.07）

2）化学療法が奏効した HTLV-I 関連肺病変の1例：松本亜紀（日本医科大学 第4内科）, 榎本達治, 根井貴仁, 榊原桂太郎, 阿部信二, 臼杵二郎, 吾妻安良太, 工藤翔二：Therapeutic Research（0289-8020）25巻7号 Page1517-1520（2004.07）

3）ステロイド療法中の間質性肺炎患者に発症したニューモシスチス肺炎の臨床的検討：榎本達治（東京都立広尾病院 呼吸器科）, 吾妻安良太, 松本亜紀, 根井貴仁, 平松久弥子, 阿部信二, 臼杵二郎, 工藤翔二：日本呼吸器学会雑誌（1343-3490）43巻12号 Page725-730（2005.12）

4）医学教育における結核 大学病院における厚生労働省モデル病室の役割：吉村明修（日本医科大学 第4内科）, 根井貴仁, 工藤翔二：結核（0022-9776）80巻12号 Page759-762（2005.12）

5）びまん性嚢胞性変化を呈した多中心性キャッスルマン病の1例：根井貴仁（日本医科大学附属病院 第4内科）, 大岩健満, 齋藤好信, 阿部信二, 茂木孝, 臼杵二郎, 吾妻安良太, 工藤翔二, 平井恭二, 小泉潔, 功刀しのぶ, 中山智子, 福田悠:日本呼吸器学会雑誌（1343-3490）44巻6号Page468-473（2006.06）

6）間質性肺炎の急性増悪に対するエンドトキシン吸着療法の試み：蔵原美鈴（日本医科大学 第4内科）, 平松久弥子, 阿部信二, 斉藤好信, 根井貴仁, 臼杵二郎, 吾妻安良太, 工藤翔二：エンドトキシン血症救命治療研究会誌（1348-821X）9巻1号 Page224-228（2005.12）

7）気管支動脈造影及び Angio CT で濃染し、血管性病変との鑑別が困難であった肺カルチノイドの1例：小野啓資（日本医科大学 内科学講座呼吸器感染腫瘍内科部門）, 根井貴仁, 弦間昭彦, 山岸茂樹, 平井恭二, 小泉潔, 田島廣之, 川本雅司, 工藤翔二：気管支学（0287-2137）28巻7号Page521-525（2006.11）

8）胸水貯留を伴い，I型アレルギーの関与が疑われた続発性肺クリプトコッカス症の1例：根井 貴仁, 榎本 達治, 坂本 徹, 神宮 亜希子, 阿部 信二, 臼杵 二郎, 吾妻 安良太, 工藤 翔二,川本 雅司, 日呼吸会誌, 45（7）：551-555, 2007.

9）急性増悪をきたした特発性上葉限局型肺線維症（網谷病）が疑われた1例: 根井 貴仁, 川本 雅司, 佐藤 悦子, 高久 多希朗, 瀬尾 宜嗣, 森本 泰介, 服部 久弥子, 齋藤 好信, 阿部 信二, 臼杵 二郎, 吾妻 安良太, 中山 智子, 福田 悠, 工藤 翔二, 弦間 昭彦, 日呼吸会誌, 47（2）：116-121, 2009